The molecular mechanism of dexamethasone-mediated effect on the blood-brain tumor barrier permeability in a rat brain tumor model

Neuroscience Letters

Volumn 452, Issue 2, 2009, Pages 114-118

  Gu, Yan ting ^a   Qin, Li juan ^b   Qin, Xin ^c   Xu, Feng ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Blood tumor barrier; Calcium activated potassium channel; Dexamethasone; Glioma

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; DEXAMETHASONE; EVANS BLUE; MIFEPRISTONE; OCCLUDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROCIRCULATION; BRAIN TUMOR; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLIOMA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN NEOPLASMS; CEREBRAL ARTERIES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; EVANS BLUE; FEMALE; INDICATORS AND REAGENTS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; MEMBRANE PROTEINS; MIFEPRISTONE; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID;

EID: 60249099517     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.12.047     Document Type: Article

References (22)

1. Andersen C. The effect of glucocorticoids in the normal cerebral hemisphere of brain tumour patients. Acta Neurol. Scand. 98 (1998) 433-438
2. Cucullo L., Hallene K., Dini G., Dal Toso R., and Janigro D. Glycerophosphoinositol and dexamethasone improve transendothelial electricalresistance in an in vitro study of the blood-brain barrier. Brain Res. 997 (2004) 147-151
3. Foerster C., Kahles T., Kietz S., and Drenckhahn D. Dexamethasone induces the expression of metalloproteinase inhibitor Timp-1 in the murine cerebral vascular endothelial cell line cEND. J. Physiol. 580 (2007) 937-949
4. Gu Y.T., Zhang H., and Xue Y.X. Dexamethasone enhances adenosine 5′-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model. Brain Res. 1162 (2007) 1-8
5. Guan Y., Rubenstein N.M., Failor K.L., and Woo P.L. Glucocorticoids control beta-catenin protein expression and localization through distinct pathways that can be uncoupled by disruption of signaling events required for tight junction formation in rat mammary epithelial tumor cells. Mol. Endocrinol. 18 (2004) 214-227
6. Hayashi Y., Yoshida Y., and Hamada J. Blood-tumor barrier in malignant brain tumor. No Shinkei Geka. 34 (2006) 983-999
7. Huang M.H., So E.C., Liu Y.C., and Wu S.N. Glucocorticoids stimulate the activity of large-conductance Ca2+ -activated K+ channels in pituitary GH3 and AtT-20 cells via a non-genomic mechanism. Steroids 71 (2006) 129-140
8. Hurst R.D., and Fritz I.B. Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood-brain barrier. J. Cell. Physiol. 167 (1996) 81-88
9. Kaup B., Schindler I., Knupfer H., and Schlenzka A. Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone. J. Neurooncol. 51 (2001) 105-110
10. Lovell P.V., King J.T., and McCobb D.P. Acute modulation of adrenal chromaffin cell BK channel gating and cell excitability by glucocorticoids. J. Neurophysiol. 91 (2004) 561-570
11. Lee S.W., Kim W.J., Park J.A., and Choi Y.K. Blood-brain barrier interfaces and brain tumors. Arch. Pharm. Res. 29 (2006) 265-275
12. Murata T., Hori M., Sakamoto K., and Karaki H. Dexamethasone blocks hypoxia-induced endothelial dysfunction in organ-cultured pulmonary arteries. Am. J. Respir. Crit. Care Med. 170 (2004) 647-655
13. Ningaraj N.S., Rao M., and Black K.L. Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier. Drug News Perspect. 16 (2003) 291-298
14. Prieto D., Rivera L., Benedito S., Recio P., Villalba N., Hernandez M., and Garcia-Sacristan A. Ca2+-activated K+ (KCa) channels are involved in the relaxations elicited by sildenafil in penile resistance arteries. Eur. J. Pharmacol. 531 (2006) 232-237
15. Salama N.N., Eddington N.D., and Fasano A. Tight junction modulation and its relationship to drug delivery. Adv. Drug Deliv. Rev. 58 (2006) 15-28
16. Shipston M.J., Kelly J.S., and Antoni F.A. Glucocorticoids block protein kinase A inhibition of calcium-activated potassium channels. J. Biol. Chem. 271 (1996) 9197-9200
17. Straathof C.S.M., van den Bent M.J., Ma J., Schmitz P.I.M., and Kros J.M. The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor. J. Neurooncol. 37 (1998) 1-8
18. Sugita M., and Black K.L. CGMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors. Cancer Res. 58 (1998) 914-920
19. Tian L., Knaus H.G., and Shipston M.J. Glucocorticoid regulation of calcium-activated potassium channels mediated by serine/threonine protein phosphatase. J. Biol. Chem. 273 (1998) 13531-13536
20. Underwood J.L., Murphy C.G., Chen J., Franse-Carman L., Wood I., Epstein D.L., and Alvarado J.A. Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. Am. J. Physiol. 277 (1999) C330-C342
21. Van R.D., Hartmann A., and Quade G. Changes of cerebral blood flow following dexamethasone treatment in brain tumour patients. A Xe/CT study. Acta Neurochir. (Wien) 143 (2001) 37-43
22. Yeung W.T.I., Lee T.Y., Del R.F., Kozak R., Bennett J., and Brown T. Effects of steroids on iopamidol blood-brain transfer constant and plasma volume in brain tumors measured with X-ray computed tomography. J. Neurooncol. 18 (1993) 53-60